Setagin and secretagogin-R22: Posttranscriptional modification products of the secretagogin gene
Authors:
- Teodora DanevaTDTeodora Daneva
- Wolfgang GartnerWGWolfgang Gartner
- Barbara BrunnmaierBBBarbara Brunnmaier
- Ivelina MinevaIMIvelina Mineva
- Tord BerggårdTBTord Berggård
- Ludwig WagnerLWLudwig Wagner
- 1 April 2005
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 329 (4) , 1193-1199
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- An expression profile of human pancreatic islet mRNAs by Serial Analysis of Gene Expression (SAGE)Diabetologia, 2004
- Nervous System Targets of RNA Editing Identified by Comparative GenomicsScience, 2003
- Calbindin D28k Exhibits Properties Characteristic of a Ca2+ SensorJournal of Biological Chemistry, 2002
- Alternative splicing: multiple control mechanisms and involvement in human diseaseTrends in Genetics, 2002
- Underediting of glutamate receptor GluR-B mRNA in malignant gliomasProceedings of the National Academy of Sciences, 2001
- Cloning and Expression of Secretagogin, a Novel Neuroendocrine- and Pancreatic Islet of Langerhans-specific Ca2+-binding ProteinJournal of Biological Chemistry, 2000
- Growth Factor/Matrix-Induced Proliferation of Human Adult β-CellsDiabetes, 1995
- Alternative Splicing of Calretinin mRNA Leads to Different Forms of CalretininEuropean Journal of Biochemistry, 1995
- Cortical neurons containing calretinin are selectively resistant to calcium overload and excitotoxicity in vitroNeuroscience, 1994
- Specific reduction of calcium-binding protein (28-kilodalton calbindin-D) gene expression in aging and neurodegenerative diseases.Proceedings of the National Academy of Sciences, 1990